The Latest Breaking News from FDA

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

The Department of Medical Sciences has warned against overconsumption of kratom-mixed beverages, saying the drink may contain a higher level of mitragynine than the Food and Drug Administration's (FDA) recommendation.

FDA testing confirms safety of dairy products in the US market, offering reassurance to consumers amid bird flu concerns.

For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients

The outbreak linked to contaminated organic walnuts sold in bulk bins has led to 12 reported cases of illness and seven hospitalizations in California and Washington.

There are plenty of challenges to blood glucose monitoring, but rumors suggest it's a top priority for Apple.

Agency announces rule on methylene chloride, colorless liquid used for stripping paint, cleaning metal and decaffeinating coffee

New red tape will result in fewer safe and effective diagnostic tests.

A survey found that 75% of American consumers are for moving nutrition facts to the front of food packages

The FDA found last week one in five commercial milk samples surveyed contained remnants of the H5N1 virus

The U.S. Food and Drug Administration (FDA) is gathering information on products of Indian spice makers MDH and Everest after Hong Kong halted sales of some of their products for allegedly containing high levels of a cancer-causing pesticide.